Ketamine IV Classic Protocol : Five Years Follow up

Completed

• Conditions: Medications; Drug Abuse; Relapse; Major Depressive Disorder

• Registration Number: NCT04824157
• Lead Sponsor: Sheba Medical Center

Brief Summary

Patients who suffer from MDD recieved ketamnie (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Detailed Description

Patients who suffer from Major Depressive disorder and are outpatients in our clinic and, received in the years (2014-15) ketamine in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Study Timeline

• Study Start: 2019-08-08
• Study First Submitted: 2019-12-23
• Primary Completion: 2020-02-28
• Study Completion: 2020-03-30
• Status Verified: 2021-03
• Study First Submitted QC: 2021-03-30
• Last Update Submitted: 2021-03-30
• Study First Posted: 2021-04-01
• Last Update Posted: 2021-04-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

• Patient who participated in ketamine study 1126

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mood that will be evaluated using the MADRAS Montgomery-Asberg Depression Rating Scale".	6 months

Trial Locations

Locations (1)

The Chaim Sheba Medical Center; 🇮🇱 Tel HaShomer, Israel